This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2006 Mar;47(3):561; author reply 562.

doi: 10.1053/j.ajkd.2005.11.031.

The effect of cholesterol-lowering treatment on renal function

Evagelos N Liberopoulos, Dimitri P Mikhailidis, Vasilios G Athyros, Moses S Elisaf

PMID: 16490637
DOI: 10.1053/j.ajkd.2005.11.031

Comment

The effect of cholesterol-lowering treatment on renal function

Evagelos N Liberopoulos et al. Am J Kidney Dis. 2006 Mar.

. 2006 Mar;47(3):561; author reply 562.

doi: 10.1053/j.ajkd.2005.11.031.

Authors

Evagelos N Liberopoulos, Dimitri P Mikhailidis, Vasilios G Athyros, Moses S Elisaf

PMID: 16490637
DOI: 10.1053/j.ajkd.2005.11.031

No abstract available

PubMed Disclaimer

Comment on

The effect of cholesterol reduction with cholestyramine on renal function.
Kshirsagar AV, Shoham DA, Bang H, Hogan SL, Simpson RJ Jr, Colindres RE. Kshirsagar AV, et al. Am J Kidney Dis. 2005 Nov;46(5):812-9. doi: 10.1053/j.ajkd.2005.08.012. Am J Kidney Dis. 2005. PMID: 16253720 Clinical Trial.

Similar articles

The effect of cholesterol reduction with cholestyramine on renal function.
Kshirsagar AV, Shoham DA, Bang H, Hogan SL, Simpson RJ Jr, Colindres RE. Kshirsagar AV, et al. Am J Kidney Dis. 2005 Nov;46(5):812-9. doi: 10.1053/j.ajkd.2005.08.012. Am J Kidney Dis. 2005. PMID: 16253720 Clinical Trial.
[Anion exchange resin].
Nakaya N. Nakaya N. Nihon Rinsho. 2001 Mar;59 Suppl 3:642-9. Nihon Rinsho. 2001. PMID: 11347147 Review. Japanese. No abstract available.
[Vasoactive agents. 48].
Richter J, Kny L, Gerecke K. Richter J, et al. Pharm Prax. 1970;12:265-6. Pharm Prax. 1970. PMID: 5498747 Review. German. No abstract available.
Regulation of hepatic cholesterol metabolism in CETP/LDLr mice by cholesterol feeding and by drugs (cholestyramine and lovastatin) that lower plasma cholesterol.
Harada LM, Carrilho AJ, Oliveira HC, Nakandakare ER, Quintão EC. Harada LM, et al. Clin Exp Pharmacol Physiol. 2006 Dec;33(12):1209-15. doi: 10.1111/j.1440-1681.2006.04512.x. Clin Exp Pharmacol Physiol. 2006. PMID: 17184503
The effect of wheat fibre on the plasma cholesterol in rats.
Kay RM, Truswell AS. Kay RM, et al. Proc Nutr Soc. 1975 May;34(1):17A-18A. Proc Nutr Soc. 1975. PMID: 1144394 No abstract available.

See all similar articles

Cited by

Statin-Induced Increase in HDL-C and Renal Function in Coronary Heart Disease Patients.
Athyros VG, Kakafika AI, Papageorgiou AA, Pagourelias ED, Savvatianos SD, Elisaf M, Karagiannis A, Tziomalos K, Mikhailidis DP. Athyros VG, et al. Open Cardiovasc Med J. 2007;1:8-14. doi: 10.2174/1874192400701010008. Epub 2007 Jul 28. Open Cardiovasc Med J. 2007. PMID: 18949085 Free PMC article.
Should a statin be prescribed to every patient with heart failure?
Tsouli SG, Liberopoulos EN, Goudevenos JA, Mikhailidis DP, Elisaf MS. Tsouli SG, et al. Heart Fail Rev. 2008 Jun;13(2):211-25. doi: 10.1007/s10741-007-9041-2. Epub 2007 Aug 12. Heart Fail Rev. 2008. PMID: 17694432 Review.
Atorvastatin decreases triacylglycerol-associated risk of vascular events in coronary heart disease patients.
Athyros VG, Kakafika AI, Papageorgiou AA, Tziomalos K, Skaperdas A, Pagourelias E, Pirpasopoulou A, Karagiannis A, Mikhailidis DP; GREACE Study Collaborative Group. Athyros VG, et al. Lipids. 2007 Nov;42(11):999-1009. doi: 10.1007/s11745-007-3103-z. Epub 2007 Aug 23. Lipids. 2007. PMID: 17713803
Dyslipidaemia of obesity, metabolic syndrome and type 2 diabetes mellitus: the case for residual risk reduction after statin treatment.
Athyros VG, Tziomalos K, Karagiannis A, Mikhailidis DP. Athyros VG, et al. Open Cardiovasc Med J. 2011;5:24-34. doi: 10.2174/1874192401105010024. Epub 2011 Feb 24. Open Cardiovasc Med J. 2011. PMID: 21660248 Free PMC article.
Patient with hypertriglyceridemia, type 2 diabetes, and chronic kidney disease treated with atorvastatin and omega-3 Fatty Acid ethyl esters.
Athyros VG, Mikhailidis DP. Athyros VG, et al. Open Cardiovasc Med J. 2012;6:122-5. doi: 10.2174/1874192401206010122. Epub 2012 Sep 20. Open Cardiovasc Med J. 2012. PMID: 23066433 Free PMC article.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science